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Introduction
Myocardial scar burden, measured by delayed hyperen-
hancement cardiac magnetic resonance (DHE-CMR), is
an independent predictor of mortality in patients with
ischemic cardiomyopathy (ICM) and severe left ventri-
cular (LV) systolic dysfunction. It is unknown if myocar-
dial scar burden impacts the protective benefit of
implantable cardioverter defibrillators (ICDs).
Purpose
In patients with severe ICM, we sought to assess the
impact of LV myocardial scarring and ICD implantation
on survival in patients with severe ICM.
Methods
Patients (n = 337) with ≥ 70% disease in ≥1 epicardial
coronary artery (77% men, median age 66 years, median
LV ejection fraction [EF] of 22 %) undergoing CMR
(Siemens 1.5-T scanner, Erlangen, Germany) between
2003-2007 were studied. CMR evaluation included long
and short axis assessment of LV function on steady
state free precession cine images along with assessment
of myocardial scar (on inversion recovery DHE-CMR
sequence ~ 10-20 minutes after injection of 0.2 mmol/
kg of Gadolinium dimeglumine). Scar was identified as
regions of interest > 2 SD above normal myocardium.
LV scar was categorized based on mean scar % and
transmural extent (0 = none, 1 = 1-25%, 2 = 26-50%,
3 = 51-75%, and 4 = > 75%). Total scar score was deter-
mined from the summed scar score of 17 segments per
patient divided by 17. 94 patients underwent subsequent
ICD implantation. The composite end-point was cardiac
transplantation and all-cause mortality. Results: Over a
follow-up of up to 8 years, there were 107 events
(102 deaths, 5 cardiac transplantations). Receiver operat-
ing characteristic curve analysis was used to select the
optimum threshold of mean scar % ≥ 33%, total scar
score ≥ 2.3 to predict death/transplantation. On multi-
variate variate analysis, only age, total scar score, dia-
betes, gender, and ICD implantation were independent
predictors of mortality/transplantation (Table 1). ICD
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Table 1 Multivariate Analysis Demonstrating
Independent Predictors of Survival in Patients with
Severe ICM
Hazard Ration (Confidence
Interval)
P-value
Age 1.04 (1.02-1.06) 0.00011
Total Scar Score 1.42 (1.16-1.73) 0.00048
Diabetes 1.91 (1.27-2.87) 0.00155
Gender 1.75 (1.13 - 2.71) 0.01
ICD 0.59 (0.36 - 0.96) 0.029
HTN 0.50
Statin 0.89
Beta-blocker 0.36
ACE-inhibitor 0.98
Post-CMR CABG 0.48
Post-CMR MV repair/
replecement
0.98
LV Ejection Fraction 0.26
LV End Diastolic Volume 0.24
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of scar burden (Figure 1 - log rank p = 0.03). However,
amongst patients with ICD, mean scar % ≥ 33% or total
scar score ≥ 2.3 was still a powerful predictor of mortal-
ity/transplantation (Figure 1 - log rank p = 0.04).
Conclusions
In patients with ICM and severe LV dysfunction, ICD
provides mortality benefit, irrespective of myocardial
scar burden. Nonetheless, scar burden remains a
powerful predictor of mortality/cardiac transplantation
even after ICD implantation.
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